Interleukin 10 promoter region polymorphisms in inflammatory bowel disease in Tunisian population

Inflamm Res. 2009 Mar;58(3):155-60. doi: 10.1007/s00011-008-8265-5.

Abstract

Objective: To test whether IL-10 promoter region polymorphisms are associated with susceptibility to inflammatory bowel disease, we examined the contribution of interleukin- 10 (IL-10) gene polymorphisms to Crohn's disease (CD) and Ulcerative colitis disease (UC) occurrence and also to CD phenotype. MATERIELS AND METHODS: SNPs at positions -627 (C > A) and -1117 (G > A) in the IL-10 promoter were determined in a sample of 105 Tunisian patients with IBD (75 CD and 30 UC) and 90 matched healthy controls.

Results: The 627 CA genotype is associated with ileal location (p = 0.015) and with stricturing (p = 510-3) and penetrating (p = 310-3) presentation of CD. An additive effect between IL10 variants and CARD15 3020 insC mutation (p = 0,006) on severe forms of CD was shown.

Conclusions: In Tunisian population, the 3020insC insertion in NOD2/CARD15 gene is a marker of susceptibility to CD, while the A allele at position -627 in the IL-10 promoter increases the risk of CD ileal location and severe disease presentation. A genetic epistasis between IL-10 gene polymorphisms and CARD15/NOD2 gene mutation was suggested.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age of Onset
  • Animals
  • Disease Susceptibility*
  • Epistasis, Genetic
  • Gene Frequency
  • Genotype
  • Humans
  • Inflammatory Bowel Diseases / genetics*
  • Interleukin-10 / genetics*
  • Nod2 Signaling Adaptor Protein / genetics
  • Polymorphism, Genetic*
  • Promoter Regions, Genetic*
  • Tunisia

Substances

  • NOD2 protein, human
  • Nod2 Signaling Adaptor Protein
  • Interleukin-10